Your browser doesn't support javascript.
loading
Anxiety and Type 1 Diabetes Management: Guardian and Child Report in a Pediatric Endocrinology Clinic.
Samuels, Susan; Menand, Emily V; Mauer, Elizabeth A; Hernandez, Sasha; Terekhova, Darya; Mathews, Tara L; Albright, Ashly A; Antal, Zoltan; Kanellopoulos, Dora.
Affiliation
  • Samuels S; Department of Psychiatry, Weill Cornell Medicine, New York, NY. Electronic address: sus9079@med.cornell.edu.
  • Menand EV; Department of Psychiatry, Weill Cornell Medicine, New York, NY.
  • Mauer EA; Department of Healthcare Policy & Research, Weill Cornell Medical College, New York, NY.
  • Hernandez S; Department of Obstetrics-Gynecology, New York University Langone, New York, NY.
  • Terekhova D; Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA.
  • Mathews TL; Department of Psychiatry, Weill Cornell Medicine, New York, NY.
  • Albright AA; Medical Student, University of Queensland School of Medicine Ochsner Clinical School, Queensland, Australia.
  • Antal Z; Department of Pediatrics, Weill Cornell Medical College, New York, NY.
  • Kanellopoulos D; Department of Psychiatry, Weill Cornell Medicine, New York, NY.
Psychosomatics ; 61(3): 231-237, 2020.
Article in En | MEDLINE | ID: mdl-31982171
ABSTRACT

BACKGROUND:

Childhood anxiety prevents optimal diabetes management yet may be underrecognized by guardians.

OBJECTIVE:

We aimed to investigate associations among anxiety, diabetes treatment adherence, and diabetes symptom control through child and guardian report.

METHODS:

Cross-sectional pilot study surveying a convenience sample of children (ages 2-21) in a pediatric endocrinology clinic. Behavior Assessment System for Children, Second Edition 2, Self-Care Inventory Report, and Pediatric Quality of Life measured anxiety, diabetes treatment adherence, and diabetes symptom control. Analyses were performed with Spearman correlations.

RESULTS:

Prevalence of anxiety and related behaviors was higher when reported by children (13% and 24%) vs. guardians (5% and 13%). Child-reported anxiety was associated with worse symptom control in all ages (Pediatric Quality of Life [rs = -0.55, P < 0.01]) and worse treatment adherence in children aged ≤12 (Self-Care Inventory Report [rho = -0.601, P = 0.023]). Guardian-reported anxiety was associated with worse symptom control (Peds QL [rs = -0.38, P = 0.02]). Child- and guardian-reported anxiety were positively correlated (rho = 0.426, P = 0.017)-particularly for children aged >12 (rho = 0.686, P = 0.003)-although not significantly for children ≤ 12 (rho = 0.201, P = 0.473).

CONCLUSION:

Anxiety in children with type 1 diabetes varies with the domain of diabetes management (treatment adherence vs. symptom control) and reporting source (child vs. guardian). Children aged ≤12 exhibited a stronger relationship between higher anxiety and worse diabetes management with worse treatment adherence and symptom control in the presence of higher anxiety. Guardians of younger children were less effective at recognizing symptoms. Challenges identifying anxiety and its detrimental effects on diabetes management suggest routine screening of anxiety in pediatric endocrinology clinics is especially salient.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Anxiety / Diabetes Mellitus, Type 1 / Legal Guardians Type of study: Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Anxiety / Diabetes Mellitus, Type 1 / Legal Guardians Type of study: Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Year: 2020 Type: Article